Artemether/lumefantrine and dihydroartemisinin/piperaquine to treat uncomplicated malaria in Ugandan children.

Trial Profile

Artemether/lumefantrine and dihydroartemisinin/piperaquine to treat uncomplicated malaria in Ugandan children.

Completed
Phase of Trial: Phase III

Latest Information Update: 23 May 2014

At a glance

  • Drugs Artemether/lumefantrine (Primary) ; Dihydroartemisinin/piperaquine (Primary)
  • Indications Falciparum malaria
  • Focus Registrational; Therapeutic Use
  • Most Recent Events

    • 23 May 2014 New trial record
    • 13 May 2014 Results published in the Clinical Infectious Diseases.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top